Extremity Reconstruction Market Key players are DePuy Synthes Stryker Corporation, Zimmer Biomet Holdings, Smith & Nephew plc, Integra Lifesciences Holdings Corporation, Wright Medical Group N.V., Acumed, Inc., Arthrex, Inc., CONMED Corporation, and Skele

The extremity reconstruction market covers implant devices for the shoulder, elbow, wrist, digits, foot, and ankle joints. The market is segmented based on the product type into upper extremity reconstruction devices and lower extremity reconstruction devices. The extremity reconstruction segment holds a small share in the global orthopedic market but it is expected to grow at the fastest rate during the study period. Hence, the leading companies have increased their focus on the segment to overcome the sluggish growth in the hip and knee joint reconstruction market.

Get the sample Report: https://www.alliedmarketresearch.com/request-sample/1716?utm_source=openpr_Niranjan

Extremity Reconstruction Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $3,041 million by 2022, registering a CAGR of 7.5% during the period 2016-2022. Shoulder reconstruction segment, which accounted for more than 70% in 2015, is expected to dominate the global market throughout the forecast period. North America held the leading position in 2015 and is expected to maintain this trend throughout.

The key drivers of the market include an increase in the incidence of joint disorders such as osteoarthritis & rheumatoid arthritis coupled with growth in the geriatric population and the global rise in the prevalence of diabetes & obesity. In addition, increase in awareness among patients about the benefits of small joint reconstruction implants and improvement of technology such as the development of stemless shoulder implants, reverse shoulder implants, and ankle reconstruction implants that assist in regaining ankle mobility are expected to propel the market growth. However, unfavorable reimbursement scenario and complications associated with extremity reconstruction surgeries hamper the market growth.

Purchase the report @Discount: https://www.alliedmarketresearch.com/checkout/148570?utm_source=openpr_Niranjan

Upper extremity reconstruction implants (such as an elbow, radius, hand & wrist, and shoulder) was the leading market segment in 2015, due to increase in the incidences of small joint disorders such as arthritis and fracture. Ankle replacement segment is expected to grow at a CAGR of 17.4%, owing to technological advancements in this segment. Technological innovations in ankle replacement implants have improved ankle motion in contrast to ankle fusion that restricts movement. Natural biomaterials segment is expected to grow rapidly due to their biocompatible and biodegradable properties.

Key Findings of the extremity reconstruction market Study:
• The shoulder replacement segment generated the highest revenue in 2015 and is projected to grow at a CAGR of 7.3%.
• Stemless shoulder implants segment is projected to grow rapidly registering a CAGR of 20%.
• Metallic biomaterial dominated the world extremity reconstruction devices market.
• Total ankle replacement segment is expected to grow at a CAGR of 17.4%.
• In 2015, the U.S. led in the global extremity reconstruction market, accounting for more than 67% share in the overall market.
• Germany accounted for about one-third share of the European extremity reconstruction market in 2015.
• Indian extremity reconstruction devices market is expected to grow at a CAGR of 13.7%.

North America accounted for a major share in 2015 and is expected to maintain this trend throughout the forecast period. This is attributed to rising in the prevalence of joint disorders coupled with an increase in geriatric population, high awareness regarding the benefits of extremity reconstruction devices, favorable reimbursement rates, presence of innovative technologies, and the quest for better quality of life in this region.

However, the Asia-Pacific region is expected to grow rapidly owing to the presence of ample growth opportunities in terms of unmet medical needs for the treatment of small joint disorders, increase in awareness about the benefits of extremity reconstruction surgeries, and rise in acceptance of advanced technologies.

Some of the key players profiled in the report include DePuy Synthes (a wholly owned subsidiary of Johnson & Johnson), Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc., Integra Lifesciences Holdings Corporation, Wright Medical Group N.V., Acumed, Inc., Arthrex, Inc., CONMED Corporation, and Skeletal Dynamics LLC.

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.